Advanced
  Home Compare Reports

Comparison with Similar Reports

Breast Reconstruction Market by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Un...

Publisher:        MarketsandMarkets

# of Pages:        241

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 37
1.1 OBJECTIVES OF THE STUDY 37
1.2 MARKET DEFINITION 37
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 38
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 YEARS CONSIDERED FOR THE STUDY 39
1.4 CURRENCY 39
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 39
1.5 LIMITATIONS 40
1.6 STAKEHOLDERS 40
1.7 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
FIGURE 1 RESEARCH DESIGN 42
2.1.1 SECONDARY DATA 43
2.1.1.1 Secondary sources 44
2.1.2 PRIMARY DATA 44
FIGURE 2 PRIMARY SOURCES 45
2.1.2.1 Key data from primary sources 46
2.1.2.2 Key industry insights 47
2.1.2.3 Breakdown of primary interviews: By company type,
designation, and region 47
2.2 MARKET SIZE ESTIMATION 48
FIGURE 3 REVENUE SHARE ANALYSIS ILLUSTRATION: SIENTRA. 48
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF BREAST RECONSTRUCTION PRODUCTS AND SERVICES 49
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 50
FIGURE 6 TOP-DOWN APPROACH 51
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 52
FIGURE 7 DATA TRIANGULATION METHODOLOGY 52
2.4 MARKET SHARE ANALYSIS 53
2.5 ASSUMPTIONS FOR THE STUDY 53
2.6 LIMITATIONS 53
2.6.1 METHODOLOGY-RELATED LIMITATIONS 53
2.7 RISK ASSESSMENT 54
TABLE 2 RISK ASSESSMENT: BREAST RECONSTRUCTION MARKET 54
2.8 COVID-19 HEALTH ASSESSMENT 54
2.9 COVID-19 ECONOMIC ASSESSMENT 55
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 55
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 55
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 57
3 EXECUTIVE SUMMARY 58
FIGURE 10 BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 58
FIGURE 11 BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION) 59
FIGURE 12 BREAST RECONSTRUCTION MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 59
FIGURE 13 BREAST RECONSTRUCTION MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 60
FIGURE 14 BREAST RECONSTRUCTION MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 61
4 PREMIUM INSIGHTS 62
4.1 BREAST RECONSTRUCTION MARKET OVERVIEW 62
FIGURE 15 RISING INCIDENCES OF BREAST CANCER EXPECTED TO DRIVE THE GROWTH OF THE MARKET DURING THE FORECAST PERIOD 62
4.2 BREAST RECONSTRUCTION BREAST IMPLANTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 63
FIGURE 16 SILICONE IMPLANT SEGMENT TO GROW AT A CAGR
DURING HE FORECAST PERIOD 63
4.3 NORTH AMERICA: BREAST RECONSTRUCTION MARKET,
BY PRODUCT AND COUNTRY (2020) 63
FIGURE 17 BREAST IMPLANTS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020 63
4.4 BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2021–2026 64
FIGURE 18 IMMEDIATE PROCEDURE SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021-2026) 64
4.5 BREAST RECONSTRUCTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 65
FIGURE 19 THE BREAST RECONSTRUCTION MARKET IN CHINA EXPECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 20 BREAST RECONSTRUCTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing incidence of breast cancer 67
TABLE 3 TOP 10 COUNTRIES WITH THE HIGHEST INCIDENCE OF
BREAST CANCER, 2020 67
TABLE 4 INCIDENCE OF BREAST CANCER, 2018 VS. 2020 VS. 2025 68
5.2.1.2 Growing aging population 68
5.2.1.3 Increasing awareness regarding breast reconstruction treatment 68
5.2.1.4 Improving reimbursements for breast reconstruction procedures 69
TABLE 5 CPT CODES FOR BREAST RECONSTRUCTION 69
5.2.2 RESTRAINTS 70
5.2.2.1 Clinical risks and complications of breast reconstruction procedures 70
5.2.2.2 Alternative non-surgical methods 70
5.2.3 OPPORTUNITIES 70
5.2.4 HIGH MARKET GROWTH POTENTIAL IN EMERGING ECONOMIES 70
5.2.4.1 Development of 3D-printed implants 71
5.2.4.2 Rise in preference for biological products 71
5.2.5 CHALLENGES 72
5.2.5.1 Product failures and recalls 72
5.2.5.2 Dearth of trained professionals 72
5.2.6 COVID-19 IMPACT ON THE BREAST RECONSTRUCTION MARKET 72
5.3 RANGES/SCENARIOS 73
5.3.1 BREAST RECONSTRUCTION MARKET 73
FIGURE 21 PESSIMISTIC SCENARIO 73
FIGURE 22 OPTIMISTIC SCENARIO 74
FIGURE 23 REALISTIC SCENARIO 74
5.4 TARIFF AND REGULATORY LANDSCAPE 75
5.4.1 NORTH AMERICA 75
5.4.1.1 US 75
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION 75
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76
5.4.1.2 Canada 76
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76
TABLE 9 BREAST LESION LOCALIZATION DEVICES CLASSIFICATION ACCORDING TO THE GOVERNMENT OF CANADA 77
5.4.2 EUROPE 77
FIGURE 24 EUROPE: CLASS III MEDICAL DEVICES 77
5.4.3 ASIA PACIFIC 78
5.4.3.1 Japan 78
TABLE 10 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 78
5.4.3.2 China 78
TABLE 11 NMPA MEDICAL DEVICES CLASSIFICATION 79
5.4.3.3 India 79
5.5 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 12 BREAST RECONSTRUCTION MARKET: PORTER’S FIVE FORCES ANALYSIS 79
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 80
5.5.2 BARGAINING POWER OF SUPPLIERS 80
5.5.3 BARGAINING POWER OF BUYERS 80
5.5.4 THREAT OF SUBSTITUTES 80
5.5.5 THREAT OF NEW ENTRANTS 80
5.6 TECHNOLOGY ANALYSIS 81
5.7 VALUE CHAIN ANALYSIS 82
FIGURE 25 VALUE CHAIN ANALYSIS FOR THE BREAST RECONSTRUCTION MARKET 82
5.8 SUPPLY CHAIN ANALYSIS 82
FIGURE 26 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 83
5.9 PATENT ANALYSIS 84
5.9.1 PATENT GRANTED TRENDS FOR BREAST RECONSTRUCTION 84
FIGURE 27 PATENT GRANTED TRENDS OF BREAST IMPLANTS,
JANUARY 2011–FEBRUARY 2022 84
FIGURE 28 PATENT GRANTED TRENDS OF ACELLULAR DERMAL MATRIX,
JANUARY 2011– FEBRUARY 2022 85
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 85
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR BREAST IMPLANTS PATENTS, JANUARY 2011—FEBRUARY 2022 86
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ACELLULAR DERMAL MATRIX, JANUARY 2011—FEBRUARY 2022 86
5.10 TRADE ANALYSIS 87
TABLE 13 IMPORT DATA FOR HS CODE 902190 - ARTICLES AND APPLIANCES, WHICH ARE WORN OR CARRIED, OR IMPLANTED IN THE BODY, TO COMPENSATE FOR A DEFECT OR DISABILITY (EXCLUDING ARTIFICIAL PARTS OF THE BODY, COMPLETE HEARING AIDS, AND COMPLETE PACEMAKERS FOR STIMULATING HEART MUSCLES), BY COUNTRY, 2016–2020 (USD MILLION) 87
TABLE 14 EXPORT DATA FOR HS CODE 902190 - ARTICLES AND APPLIANCES, WHICH ARE WORN OR CARRIED, OR IMPLANTED IN THE BODY, TO COMPENSATE FOR A DEFECT OR DISABILITY (EXCLUDING ARTIFICIAL PARTS OF THE BODY, COMPLETE HEARING AIDS, AND COMPLETE PACEMAKERS FOR STIMULATING HEART MUSCLES), BY COUNTRY, 2016–2020 (USD MILLION) 88
5.11 PRICING ANALYSIS 88
TABLE 15 PRICE OF BREAST RECONSTRUCTION PRODUCTS (USD) 88
TABLE 16 AVERAGE COST OF BREAST RECONSTRUCTION SURGERY
USING IMPLANTS (USD) 88
5.12 KEY CONFERENCES & EVENTS IN 2022-2023 89
TABLE 17 BREAST RECONSTRUCTION MARKET: DETAILED LIST OF CONFERENCES & EVENTS 89
5.13 ECOSYSTEM ANALYSIS 91
FIGURE 31 ECOSYSTEM OF THE BREAST HEALTH INDUSTRY 91
5.13.1 ROLE IN THE ECOSYSTEM 92
FIGURE 32 KEY PLAYERS IN THE BREAST RECONSTRUCTION ECOSYSTEM 93
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR BREAST RECONSTRUCTION PRODUCTS MANUFACTURERS OR SERVICE PROVIDERS 94
FIGURE 33 REVENUE SHIFT FOR BREAST RECONSTRUCTION PRODUCTS 94
 
6 BREAST RECONSTRUCTION MARKET, BY PRODUCT 95
6.1 INTRODUCTION 96
TABLE 18 US: PRODUCTS USED FOR BREAST RECONSTRUCTION PROCEDURES, 2020 96
TABLE 19 BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 96
TABLE 20 BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 96
6.2 BREAST IMPLANT 97
TABLE 21 US: TYPES OF BREAST IMPLANTS USED FOR BREAST RECONSTRUCTION PROCEDURES, 2020 97
TABLE 22 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY REGION, 2018–2020 (USD MILLION) 97
TABLE 23 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY REGION, 2021–2026 (USD MILLION) 98
6.2.1 BREAST IMPLANTS MARKET, BY TYPE 98
TABLE 24 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY TYPE,
2018–2020 (USD MILLION) 98
TABLE 25 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANT, BY TYPE,
2021–2026 (USD MILLION) 98
6.2.1.1 Silicone implants 99
6.2.1.1.1 Silicone breast implants expected to dominate the breast implants market due to their benefits 99
TABLE 26 SILICONE BREAST IMPLANTS MARKET, BY REGION,
2018–2020 (USD MILLION) 99
TABLE 27 SILICONE BREAST IMPLANTS MARKET, BY REGION,
2021–2026 (USD MILLION) 99
6.2.1.2 Saline Implants 100
6.2.1.2.1 Low cost of implants to drive market growth 100
TABLE 28 SALINE IMPLANTS MARKET, BY REGION, 2018–2020 (USD MILLION) 100
TABLE 29 SALINE IMPLANTS MARKET, BY REGION, 2021–2026 (USD MILLION) 100
6.2.2 BREAST IMPLANTS MARKET, BY SHAPE 101
TABLE 30 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 101
TABLE 31 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 101
6.2.2.1 Round implants 101
6.2.2.1.1 Round implants show the highest end-user demand and market growth 101
TABLE 32 ROUND BREAST IMPLANT MARKET, BY REGION, 2018–2020 (USD MILLION) 102
TABLE 33 ROUND BREAST IMPLANT MARKET, BY REGION, 2021–2026 (USD MILLION) 102
6.2.2.2 Anatomical implants 102
6.2.2.2.1 Increasing implant-based breast reconstruction procedures will support the market growth 102
TABLE 34 ANATOMICAL BREAST IMPLANT MARKET, BY REGION,
2018–2020 (USD MILLION) 103
TABLE 35 ANATOMICAL BREAST IMPLANT MARKET, BY REGION,
2021–2026 (USD MILLION) 103
6.3 TISSUE EXPANDER 103
6.3.1 RISING NUMBER OF BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH 103
TABLE 36 BREAST RECONSTRUCTION MARKET FOR TISSUE EXPANDER, BY REGION, 2018–2020 (USD MILLION) 104
TABLE 37 BREAST RECONSTRUCTION MARKET FOR TISSUE EXPANDER, BY REGION, 2021–2026 (USD MILLION) 104
6.4 ACELLULAR DERMAL MATRIX 104
6.4.1 RISING NUMBER OF ACELLULAR DERMAL MATRIX BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH 104
TABLE 38 BREAST RECONSTRUCTION MARKET FOR ACELLULAR DERMAL MATRIX,
BY REGION, 2018–2020 (USD MILLION) 105
TABLE 39 BREAST RECONSTRUCTION MARKET FOR ACELLULAR DERMAL MATRIX,
BY REGION, 2021–2026 (USD MILLION) 105
7 BREAST RECONSTRUCTION MARKET, BY PROCEDURE 106
7.1 INTRODUCTION 107
TABLE 40 US: IMMEDIATE AND DELAYED BREAST RECONSTRUCTION PROCEDURES PERFORMED, 2020 107
TABLE 41 BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 107
TABLE 42 BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 107
7.2 IMMEDIATE PROCEDURES 108
7.2.1 IMMEDIATE PROCEDURES WAS THE LARGEST MARKET SEGMENT 108
TABLE 43 IMMEDIATE BREAST RECONSTRUCTION PROCEDURES MARKET,
BY REGION, 2018–2020 (USD MILLION) 108
TABLE 44 IMMEDIATE BREAST RECONSTRUCTION PROCEDURES MARKET,
BY REGION, 2021–2026 (USD MILLION) 109
7.3 DELAYED PROCEDURES 109
7.3.1 RISING AWARENESS WILL SUPPORT MARKET GROWTH 109
TABLE 45 DELAYED BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2018–2020 (USD MILLION) 109
TABLE 46 DELAYED BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2021–2026 (USD MILLION) 110
7.4 REVISION PROCEDURES 110
7.4.1 DISSATISFACTION AND AESTHETIC ISSUES DRIVE DEMAND FOR REVISION 110
TABLE 47 REVISION BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2018–2020 (USD MILLION) 110
TABLE 48 REVISION BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2021–2026 (USD MILLION) 111
 
8 BREAST RECONSTRUCTION MARKET, BY TYPE 112
8.1 INTRODUCTION 113
TABLE 49 US: UNILATERAL AND BILATERAL BREAST RECONSTRUCTION PROCEDURES PERFORMED, 2020 113
TABLE 50 BREAST RECONSTRUCTION MARKET, BY TYPE, 2018–2020 (USD MILLION) 113
TABLE 51 BREAST RECONSTRUCTION MARKET, BY TYPE, 2021–2026 (USD MILLION) 113
8.2 UNILATERAL BREAST RECONSTRUCTION 114
8.2.1 UNILATERAL RECONSTRUCTION DOMINATES THE MARKET, BY TYPE 114
TABLE 52 UNILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,
2018–2020 (USD MILLION) 114
TABLE 53 UNILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,
2021–2026 (USD MILLION) 114
8.3 BILATERAL 115
8.3.1 APAC TO SHOW HIGHEST GROWTH IN THE MARKET FOR BILATERAL
BREAST RECONSTRUCTION 115
TABLE 54 BILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,
2018–2020 (USD MILLION) 115
TABLE 55 BILATERAL BREAST RECONSTRUCTION MARKET, BY REGION,
2021–2026 (USD MILLION) 115
9 BREAST RECONSTRUCTION MARKET, BY END USER 116
9.1 INTRODUCTION 117
TABLE 56 BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 117
TABLE 57 BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 117
9.2 HOSPITALS 117
9.2.1 HOSPITALS TO DOMINATE THE BREAST RECONSTRUCTION MARKET DURING THE FORECAST PERIOD 117
TABLE 58 BREAST RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION,
2018–2020 (USD MILLION) 118
TABLE 59 BREAST RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION,
2021–2026 (USD MILLION) 118
9.3 COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS 119
9.3.1 GROWING PREFERENCE FOR OUTPATIENT TREATMENT AND PROCEDURES OVER HOSPITAL CARE DRIVES MARKET GROWTH 119
TABLE 60 BREAST RECONSTRUCTION MARKET FOR COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2020 (USD MILLION) 119
TABLE 61 BREAST RECONSTRUCTION MARKET FOR COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2021–2026 (USD MILLION) 119
9.4 COVID-19 ANALYSIS 120
 
10 BREAST RECONSTRUCTION MARKET, BY REGION 121
10.1 INTRODUCTION 122
TABLE 62 BREAST RECONSTRUCTION MARKET, BY REGION,
2018–2020 (USD MILLION) 122
TABLE 63 BREAST RECONSTRUCTION MARKET, BY REGION,
2021–2026 (USD MILLION) 122
10.2 NORTH AMERICA 123
FIGURE 34 NORTH AMERICA: BREAST RECONSTRUCTION MARKET SNAPSHOT 124
TABLE 64 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2018–2020 (USD MILLION) 124
TABLE 65 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 125
TABLE 66 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 125
TABLE 67 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 125
TABLE 68 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 126
TABLE 69 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 126
TABLE 70 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 126
TABLE 71 NORTH AMERICA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 127
TABLE 72 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2018–2020 (USD MILLION) 127
TABLE 73 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2021–2026 (USD MILLION) 127
TABLE 74 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 128
TABLE 75 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 128
TABLE 76 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 128
TABLE 77 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 129
10.2.1 US 129
10.2.1.1 The US dominates the North American breast reconstruction market 129
TABLE 78 US: BREAST RECONSTRUCTIVE PROCEDURES PERFORMED IN 2020, BY TYPE 130
TABLE 79 US: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 130
TABLE 80 US: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 130
TABLE 81 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 131
TABLE 82 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 131
TABLE 83 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 131
TABLE 84 US: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 132
TABLE 85 US: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 132
TABLE 86 US: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 132
TABLE 87 US: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 133
TABLE 88 US: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 133
TABLE 89 US: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 133
TABLE 90 US: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 133
10.2.2 CANADA 134
10.2.2.1 Increasing incidence of breast cancer will drive
market growth in Canada 134
TABLE 91 CANADA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 134
TABLE 92 CANADA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 134
TABLE 93 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 135
TABLE 94 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 135
TABLE 95 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 135
TABLE 96 CANADA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 136
TABLE 97 CANADA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 136
TABLE 98 CANADA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 136
TABLE 99 CANADA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 137
TABLE 100 CANADA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 137
TABLE 101 CANADA: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 137
TABLE 102 CANADA: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 138
10.3 EUROPE 138
TABLE 103 INCIDENCE OF BREAST CANCER IN EUROPEAN COUNTRIES, 2020 VS. 2040 138
TABLE 104 MASTECTOMY SURGERIES PERFORMED IN EUROPE, BY COUNTRY, 2019 138
TABLE 105 EUROPE: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2018–2020 (USD MILLION) 139
TABLE 106 EUROPE: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 139
TABLE 107 EUROPE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 139
TABLE 108 EUROPE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 140
TABLE 109 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 140
TABLE 110 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 140
TABLE 111 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 141
TABLE 112 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 141
TABLE 113 EUROPE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 141
TABLE 114 EUROPE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 142
TABLE 115 EUROPE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 142
TABLE 116 EUROPE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 142
TABLE 117 EUROPE: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 143
TABLE 118 EUROPE: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 143
10.3.1 GERMANY 143
10.3.1.1 Germany dominates the European breast reconstruction market 143
TABLE 119 GERMANY: BREAST CANCER INCIDENCE, 2018 VS. 2025 143
TABLE 120 GERMANY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 144
TABLE 121 GERMANY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 144
TABLE 122 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 144
TABLE 123 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 145
TABLE 124 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 145
TABLE 125 GERMANY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 145
TABLE 126 GERMANY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 146
TABLE 127 GERMANY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 146
TABLE 128 GERMANY: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 146
TABLE 129 GERMANY: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 147
TABLE 130 GERMANY: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 147
TABLE 131 GERMANY: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 147
10.3.2 FRANCE 147
10.3.2.1 Rising geriatric population will drive market growth 147
TABLE 132 FRANCE: BREAST CANCER INCIDENCE, 2018 VS. 2025 148
TABLE 133 FRANCE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 148
TABLE 134 FRANCE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 148
TABLE 135 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 148
TABLE 136 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 149
TABLE 137 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 149
TABLE 138 FRANCE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 149
TABLE 139 FRANCE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 150
TABLE 140 FRANCE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 150
TABLE 141 FRANCE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 150
TABLE 142 FRANCE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 151
TABLE 143 FRANCE: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 151
TABLE 144 FRANCE: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 151
10.3.3 UK 152
10.3.3.1 Rising incidences of breast cancer will support market growth 152
TABLE 145 UK: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 152
TABLE 146 UK: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 152
TABLE 147 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 153
TABLE 148 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 153
TABLE 149 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION) 153
TABLE 150 UK: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION) 154
TABLE 151 UK: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 154
TABLE 152 UK: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 154
TABLE 153 UK: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 155
TABLE 154 UK: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 155
TABLE 155 UK: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 155
TABLE 156 UK: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 156
10.3.4 ITALY 156
10.3.4.1 Rising geriatric population in Italy to drive the market 156
TABLE 157 ITALY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 156
TABLE 158 ITALY: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 157
TABLE 159 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 157
TABLE 160 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 157
TABLE 161 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 158
TABLE 162 ITALY: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 158
TABLE 163 ITALY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 158
TABLE 164 ITALY: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 159
TABLE 165 ITALY: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 159
TABLE 166 ITALY: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 159
TABLE 167 ITALY: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 159
TABLE 168 ITALY: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 160
10.3.5 SPAIN 160
10.3.5.1 Silicone implants show high acceptance in Spain 160
TABLE 169 SPAIN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 160
TABLE 170 SPAIN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 161
TABLE 171 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 161
TABLE 172 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 161
TABLE 173 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 162
TABLE 174 SPAIN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 162
TABLE 175 SPAIN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 162
TABLE 176 SPAIN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 163
TABLE 177 SPAIN: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 163
TABLE 178 SPAIN: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 179 SPAIN: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 164
TABLE 180 SPAIN: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 164
10.3.6 REST OF EUROPE 164
TABLE 181 ROE: BREAST CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040 164
TABLE 182 ROE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 165
TABLE 183 ROE: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 165
TABLE 184 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION) 165
TABLE 185 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION) 166
TABLE 186 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 166
TABLE 187 ROE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 166
TABLE 188 ROE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 167
TABLE 189 ROE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 167
TABLE 190 ROE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 167
TABLE 191 ROE: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 192 ROE: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 168
TABLE 193 ROE: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 168
10.4 ASIA PACIFIC 169
FIGURE 35 ASIA PACIFIC: BREAST RECONSTRUCTION MARKET SNAPSHOT 170
TABLE 194 APAC: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2018–2020 (USD MILLION) 170
TABLE 195 APAC: BREAST RECONSTRUCTION MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 171
TABLE 196 APAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 171
TABLE 197 APAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 171
TABLE 198 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 172
TABLE 199 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 172
TABLE 200 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 172
TABLE 201 APAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 173
TABLE 202 APAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 173
TABLE 203 APAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 173
TABLE 204 APAC: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 174
TABLE 205 APAC: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 174
TABLE 206 APAC: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 174
TABLE 207 APAC: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 175
10.4.1 CHINA 175
10.4.1.1 China accounts for the largest share of the APAC market 175
TABLE 208 CHINA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 175
TABLE 209 CHINA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 176
TABLE 210 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 176
TABLE 211 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 176
TABLE 212 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 177
TABLE 213 CHINA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 177
TABLE 214 CHINA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 177
TABLE 215 CHINA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 178
TABLE 216 CHINA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 178
TABLE 217 CHINA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 178
TABLE 218 CHINA: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 179
TABLE 219 CHINA: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 179
10.4.2 JAPAN 179
10.4.2.1 Growing awareness of cosmetic surgery to drive the market in Japan 179
TABLE 220 JAPAN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 180
TABLE 221 JAPAN: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 180
TABLE 222 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 180
TABLE 223 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 181
TABLE 224 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 181
TABLE 225 JAPAN: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 181
TABLE 226 JAPAN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 182
TABLE 227 JAPAN: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 182
TABLE 228 JAPAN: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 182
TABLE 229 JAPAN: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 183
TABLE 230 JAPAN: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 183
TABLE 231 JAPAN: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 183
10.4.3 INDIA 184
10.4.3.1 Market growth in India is primarily driven by the rising incidence of breast cancer 184
TABLE 232 INDIA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 184
TABLE 233 INDIA: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 184
TABLE 234 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 185
TABLE 235 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 185
TABLE 236 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 185
TABLE 237 INDIA: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 186
TABLE 238 INDIA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 186
TABLE 239 INDIA: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 186
TABLE 240 INDIA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 187
TABLE 241 INDIA: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 187
TABLE 242 INDIA: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 187
TABLE 243 INDIA: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 187
10.4.4 REST OF ASIA PACIFIC 188
TABLE 244 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2018–2020 (USD MILLION) 188
TABLE 245 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 188
TABLE 246 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2018–2020 (USD MILLION) 189
TABLE 247 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY TYPE, 2021–2026 (USD MILLION) 189
TABLE 248 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2018–2020 (USD MILLION) 189
TABLE 249 ROAPAC: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS,
BY SHAPE, 2021–2026 (USD MILLION) 190
TABLE 250 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2018–2020 (USD MILLION) 190
TABLE 251 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PROCEDURE,
2021–2026 (USD MILLION) 190
TABLE 252 ROAPAC: BREAST RECONSTRUCTION MARKET, BY TYPE,
2018–2020 (USD MILLION) 191
TABLE 253 ROAPAC: BREAST RECONSTRUCTION MARKET, BY TYPE,
2021–2026 (USD MILLION) 191
TABLE 254 ROAPAC: BREAST RECONSTRUCTION MARKET, BY END USER,
2018–2020 (USD MILLION) 191
TABLE 255 ROAPAC: BREAST RECONSTRUCTION MARKET, BY END USER,
2021–2026 (USD MILLION) 191

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127